News

24/52 Liver Disease (EME Programme)

Published on: 04/07/2024

24/52 Liver Disease (EME Programme)

The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to this funding opportunity.

Funding, Opportunities
Funding news

In order to apply you will need to carefully review the:

The EME application supporting information provides further details on:

  • eligibility
  • collaboration and team expertise
  • timescales
  • funding limits
  • guidance on applying

This is a cross-programme funding opportunity, and research proposals must fall within the remit of at least one of the participating NIHR Programmes. Applications which span the remit of one or more of the participating NIHR Programmes are also welcomed. The Programmes involved in this funding opportunity are:

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.

NEWS​

Related News

ATA Insights Summit 2025: Peer-Driven Strategy Labs for Redesigning Care Delivery

19 Jun 2025

NATO Diana Accelerator Program

18 Jun 2025

4P-CAN at the Cancer Thematic Innovation Ecosystem

18 Jun 2025

A week of impactful engagements for Gravitate-Health

18 Jun 2025

Disrupt or Be Disrupted: Global Digital Health Summit Is Where Health Leaders Gather

18 Jun 2025

Discover AGORA – The Digital Gateway to Innovation Procurement in Healthcare

18 Jun 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *